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DISCUSSIO
The gross and histopathological features as well as the
site of the soft-tissue lesion deep to the scapula were con-
sistent with the diagnosis of elastofibroma dorsi. As yet,
the only other site reported has been in the region of the
deltoid muscle.' One should always be aware of this
condition, since it may be incorrectly diagnosed clinically
as a sarcoma.' However, elastofibroma never behaves like
an aggressive neoplasm and lacks the morphological ap·
pearance of one. The natural history suggests a benign
lesion apparently associated with a reactive or degene-
rative process:'· Mackenzie eE al.' have reported that these
lesions may result from trauma, which appears to have
been the case in the patient described, since there was a
definite association of underlying trauma in the develop-
ment of the lesion. Local excision seems to be adequate
treatment.
I wish to thank Dr M. Addison, Regional Director of the
Soulh African InstilUle for Medical Research, Port Elizabelh
Branch, for reading the article and for permission to publish,
lhe Medical Superintendent, Dr J. Wessels, Dr L. Krause
of the Provincial Hospital, Port Elizabeth, and Professor
N. S. F. Proctor for his assistance wilh the photograph.
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Hodgkin's Disease and Acute Promyelocytic Leukaemia
A Case Report
W. J. C. J. ROSENSTRAUCH, A. M. VAN DER MERWE,
P. J. VAN EEDEN, J. G. STEYTLER
J. B. KiNG,
SUMMARY
A case of Hodgkin's disease is reported in which acute
promyelocytic le... kaemia developed with:n 5 months of
initiation of chemotherapy. Only 3 other cases, possibly of
a similar nature, were found in the literature; these had
occurred 15, 77, and 226 months respectively after the
initial diagnosis of Hodgkin's disease.
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During the past 6 years it has become increasingly appa-
rent that patients with Hodgkin's disease (HO), especially
those treated with both high-level radiation and intensive
chemotherapy, have a greatly increased risk of develop-
ing leukaemia. Coleman et al.' reported an incidence of
nearly 4% in those patients treated with combination
radiation and chemotherapy; the overall incidence was
only 2°{,. It has been suggested that the leukaemia may
be a part of the natural history of HO, seen more often
now because of improved survival; or that it is a com-
plication of aggressive therapy.'-' The latent period from
the diagnosis of HD to the diagnosis of acute non-
lymphocytic leukaemia (A ILL) ranged from 8 months
to ] 9 years:'o In cases in which the leukaemia was diag-
nosed within 6 months of the diagnosis of HO, the leukae-
mia has been regarded as co-incidental, probably not
secondary to H D or to its therapy.'
One hundred and sixteen patients with HO were treated
at Tygerberg Hospital between ] 970 and 1979; 1 of these
--
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patients developed acute promyelocytic leukaemia (APL).
It is the purpose of this article to report the development
vf acute APL and diffuse intravascular coagulation within
5 months of initiating chemotherapy in a patient with HO.
CASE REPORT
A 33-year-old man was admitted in October 1978 with
symptoms of fever, loss of weight and enlarged left
axillary lymph nodes. Two years previously he had
sustained an injury to the left arm; a swelling subse-
quently developed medially to the elbow. One month
before admission he noticed swelling of the left pectoral
area and enlargement of the lymph nodes in the left
axilla (Fig. 1). These increased progressively, fever and
sweating ensued, and he lost 7 kg in weight. The spleen
was palpable 12 cm below the costal margin. The liver
was not enlarged. Biopsy of the elbow mass showed a
subacute abscess, while histological examination of the
axillary lymph nodes revealed HO (nodular sclerosing
type). Several Reed-Sternberg cells were present (Fig. 2).
The haematocrit was 30% and the white cell count was
24 x 10'/1 with 85'% neutrophils, 13 % Iymphocytes and
2 o~ eosinophils. The platelet count was 220 x 10'/1 and
the reticulocyte count 80 x 10'/ I. The blood smear
showed normochromic, normocytic red blood cells. Blood
urea and electrolyte values and liver function were normal.
Staging trephine biopsy of the bone marrow revealed no
signs of HO, and aspiration showed the marrow to be
normal and active. The patient was regarded as having
clinical stage IIIb HO.
Fig. 1. Fhotograph of left axilla demonstrating massivel)'
enlarged I)'mph nodes.
Treatment was commenced. Five cour es of nitrogen
mustard, Vinblastine, procarbazine and prednisone were
administered from [ovember 1978 to March 1979. The
haematocrit and the white .cell count returned to normal.
The serum copper value, initially 38 "amolll, reverted to
normal levels and the ] 2 cm enlarged spleen shrank to
2 cm below the costal margin.
Five month after initiation of therapy the patient
retumed to the hospital because of persistent severe
epistaxis. No rash or peripheral lymphadenopathy was
found, and the liver and spleen were normal in size. The
heart and lungs were normal. [0 enlargement of the
media tinal lymph nodes was een on che t radiographs.
The haematocrit was 20%, the platelet count 30 x 10'/1
and the white cell count 5,3 x ] 0' /1. The red blood
cell were normochromic with numerous fragmented red
blood cells observed on the smear. Only a few platelets
were visible. The granulocyte eries \ as shifted to the
left with 5% promyelocytes. Bone marrow aspiration and
biopsy disclosed myeloid hyperplasia with suppression of
erythropoiesis. The predominant cell (42~o) was an atypi-
cal promyelocyte (Fig. 3), containing numerous Auer
body-like inclusions, and the megakaryocytes were re-
duced in number. The appearance was consistent with
APL.
Plasma and urine muramidase levels were within normal
limits. The bleeding time was ]4 minutes (normal U- 7
minutes), prothrombin activity 23°~ (normal 70 - ]20%),
the prothrombin ratio ],62 (normal ],0 - 1,3), and the
Fig. 2. L)'l1Iph node biops)' showing nodular sclerosing
t)'pe HO (H and E x 400).
Fig. 3. Photomicrograph of hone marrow showing dell5e-
I)' staining granules and crystalline inclusions in cells of
the l1I)'eloid series. The predominant cells are at)'pical
prol1l)'eloCJtes (Ma)'-Griinwald-Giemsa x ] 000).
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partial thromboplastin time 35,5 s (normal 25 - 45 s).
Other biochemical values were fibrinogen 570 mg/dl
(normal 200 - 400 mg/dl) and fibrinogen degradation pro-
ducts 40 ,u.g/ml (normal less than 10 ,u.g/ml); the fibrino-
gen monomer test was positive (ethanol gelation test). The
picture wa consistent with diffuse intravascular coagula-
tion.
Fresh-frozen plasma, single donor platelets and thawed
frozen red blood cells were transfused. Adriamycin, ara-
binoside C and a continuous intravenous infusion of
heparin 6000 U /24 h were commenced, reverse barrier
nursing procedures were initiated, and intravenous
cephalosporin, aminoglycoside and oral co-trimoxazole
were administered. Two days after admission the patient
became comatose, developed neck stiffness and decere-
brate rigidity, and died. Autopsy was refused.
In summary, the patient suffered from HD and de-
veloped APL with diffuse intravascular coagulation with-
in 5 months of beginning chemotherapy.
DISCUSSION
The term 'acute promyelocytic leukaemia' describes a
special type of acute non-lymphocytic leukaemia charac-
terized by severe bleeding manifestations which are fre-
quently fatal. Atypical promyelocytes are present in the
peripheral blood and bone marrow and contain large
azurophilic granules. Thrombocytopenia and abnormal
clotting tests reflect disseminated intravascular coagula-
tion: APL probably represents 6°~ of all cases of acute
leukaemia or 13 o~ of all cases of ANLLY
Acute leukaemia has been reported to be the terminal
event in more than 100 patients with BD.'·'···o,. The esti-
mated incidence of leukaemia in treated BD patients is
about 1o~: Only 1 of 116 patients treated at Tygerberg
Hospital developed ANLL
The mean interval from the diagnosis of the BD to the
occurrence of A TLL in reported cases was 6,5 years,'
with a range of 8 months - 19 years.o Although all
patients had acute myelocytic leukaemia or one of its
variants, the term 'acute promyelocytic leukaemia' was
not used. APL rarely presents as a terminal event follow-
ing another haematological disorder.'o
ewman et al." reported 2 patients who developed
acute myelomonocytic leukaemia 18 years 10 months and
15 months after the onset of BD. Both had received
radiotherapy. One of them was without complaints when
a routine check-up revealed thrombocytopenia and 63%
blast cells in the peripheral blood. The bone marrow
aspirate was hypercellular, with a decrease in erythro-
poiesis and 80 0 h promyelocytes. Ten per cent of the
granulocyte series were blasts with frequent Auer bodies.
f O megakaryocytes were present in the specimen. The
patient died 1 month later owing to progression of the
disease, which was complicated by a bleeding gastric
ulcer, haematuria, ecchymosis and neurological involve-
ment. Although this was regarded as acute 'myelomono-
cytic leukaemia, the symptoms could well have been
those of APL also. Newman's second patient presented
with anaemia, leucopenia, purpura and haematuria 15
months after HD had been diagnosed. The bone marrow
aspirate was hypercellular, and the predominant cell was
an atypical promyelocyte, sometimes containing 40 - 50
Auer bodies. The patient died of intracerebral haemor-
rhage, and the case appeared to be a typical one of APL.
In a comprehensive review of 74 cases Rosner and
Grunwald' reported 8 patients treated by themselves who
had HD and acute leukaemia. Of these, patient 7, who is
described as having a nodular sclerosing type of BD, had
received radiotherapy initially, followed 6 years later by
3 courses of nitrogen mustard, vinblastine, procarbazine
and prednisone. Five months later she developed aplastic
anaemia, and chemotherapy was discontinued. One month
later the bone marrow showed leukaemia with hyper-
cellularity and I8'oh blast cells and 80% promyelocytes.
She died of a cerebral haemorrhage. The authors did not
find any Auer bodies and did not discuss APL.
These are the only possible cases we found in the English
literature till 1979, after consulting the computerized
MEDLARS request facilities of the South African Medi-
cal Research Council. The acute leukaemia occurred a
considerable time after initiation of therapy. Chloram-
bucil, used as maintenance therapy in the treatment of
HO, was proved to initiate acute leukaemia." Nitrogen
mustard and procarbazine may also contribute. Cadman
er al: presented a critical analysis of 109 cases reported
in the world literature until March 1976, and proposed
that when the leukaemia was diagnosed within 6 months
of the diagnosis of BD, it should be considered to be co-
incidental, and probably not due to the HD therapy.
In our patient the occurrence was not simultaneoUs,
since the bone marrow was normal at the time of diag-
nosis of BD.
The relationship between BD and acute leukaemia
remains unclear. There are no apparent characteristics of
BD which predict which patients will develop ANLL.
In all of the well-documented cases the patients had
received either radiation or chemotherapy or both.
It appears that BD does not evolve into acute leukae-
mia, but rather that ANLL develops as a second malig-
nancy in these patients, whether or not they still have
active HDY 'Whether the leukemogenic effect is due to
an immunologic defect or is the result of a direct injury
to myeloid cells by radiation and chemical agents is not
established and will have to await a better understanding
of the cause and pathogenesis of leukemia'.13
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